Author:
Jacquemier Jocelyne,Boher Jean-Marie,Roche Henri,Esterni Benjamin,Serin Daniel,Kerbrat Pierre,Andre Fabrice,Finetti Pascal,Charafe-Jauffret Emmanuelle,Martin Anne-Laure,Campone Mario,Viens Patrice,Birnbaum Daniel,Penault-Llorca Frédérique,Bertucci François
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005, 365: 1687-1717.
2. Sparano JA, Hortobagyi GN, Gralow JR, Perez EA, Comis RL: Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization. Breast Cancer Res Treat. 2010, 119: 511-527. 10.1007/s10549-009-0433-y.
3. Bedard PL, Di Leo A, Piccart-Gebhart MJ: Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer. Nat Rev Clin Oncol. 2010, 7: 22-36. 10.1038/nrclinonc.2009.186.
4. Buzdar AU, Singletary SE, Valero V, Booser DJ, Ibrahim NK, Rahman Z, Theriault RL, Walters R, Rivera E, Smith TL, Holmes FA, Hoy E, Frye DK, Manuel N, Kau SW, McNeese MD, Strom E, Thomas E, Hunt K, Ames F, Berry D, Hortobagyi GN: Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial. Clin Cancer Res. 2002, 8: 1073-1079.
5. Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E, Schilsky RL, Wood WC, Muss HB, Norton L: Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol. 2003, 21: 976-983. 10.1200/JCO.2003.02.063.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献